Literature DB >> 20082128

Assessing maternal risk for fetal-infant mortality: a population-based study to prioritize risk reduction in a healthy start community.

Catherine L Kothari1, Annie Wendt, Oemeeka Liggins, Jacqueline Overton, Luz del Carmen Sweezy.   

Abstract

Study goals were to distinguish between maternal risk factors for fetal versus infant mortality, and to identify which maternal characteristics contributed the greatest risk of mortality overall. This case-control retrospective study abstracted data on more than forty maternal characteristics from 261 prenatal and delivery records: all 26 fetal deaths, all 40 infant deaths and 195 randomly selected surviving births in a high-mortality Healthy Start community. Bivariate and multivariate analyses were conducted. The fetal-mortality population was significantly more likely than the infant-mortality population to have no insurance (P = .047), inadequate prenatal care (P = .039) and previous fetal death (P = .021). Comparing the combined mortality population with the surviving sample, two tiers of risk emerged: Rare-but-lethal risks, including no prenatal care (P < .001) and Child-Protective-Service involvement (P = .001), and common-and-dangerous risks, including inadequate maternal weight gain (OR = 13.55), drug or alcohol abuse (OR = 8.67), obesity (OR = 2.77) and anemia (OR = 3.61). Both fetal and infant mortality groups must be considered when identifying maternal risks. Inadequate prenatal weight gain, obesity and anemia contribute as much to feto-infant mortality as substance abuse. Public health efforts to improve maternal nutrition and healthy weight should be redoubled.

Entities:  

Mesh:

Year:  2011        PMID: 20082128     DOI: 10.1007/s10995-009-0561-3

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  32 in total

1.  Adverse perinatal outcomes associated with homelessness and substance use in pregnancy.

Authors:  Merry Little; Rajiv Shah; Marian J Vermeulen; Alice Gorman; Darlene Dzendoletas; Joel G Ray
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

2.  Effects of case management on retention in prenatal substance abuse treatment.

Authors:  M P Laken; J W Ager
Journal:  Am J Drug Alcohol Abuse       Date:  1996-08       Impact factor: 3.829

Review 3.  Sexually transmitted diseases: magnitude, determinants and consequences.

Authors:  S O Aral
Journal:  Int J STD AIDS       Date:  2001-04       Impact factor: 1.359

4.  The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida.

Authors:  I J Chasnoff; H J Landress; M E Barrett
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

5.  Why screen newborns for cocaine: service patterns and social outcomes at age one year.

Authors:  R S Byrd; A M Neistadt; C R Howard; C Brownstein-Evans; M Weitzman
Journal:  Child Abuse Negl       Date:  1999-06

6.  Early access to prenatal care: implications for racial disparity in perinatal mortality.

Authors:  Andrew J Healy; Fergal D Malone; Lisa M Sullivan; T Flint Porter; David A Luthy; Christine H Comstock; George Saade; Richard Berkowitz; Susan Klugman; Lorraine Dugoff; Sabrina D Craigo; Ilan Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Diana W Bianchi; Mary E D'Alton
Journal:  Obstet Gynecol       Date:  2006-03       Impact factor: 7.661

7.  The clinical content of preconception care: nutrition and dietary supplements.

Authors:  Paula M Gardiner; Lauren Nelson; Cynthia S Shellhaas; Anne L Dunlop; Richard Long; Sara Andrist; Brian W Jack
Journal:  Am J Obstet Gynecol       Date:  2008-12       Impact factor: 8.661

Review 8.  The effects of drug abuse on pregnancy.

Authors:  Krzysztof M Kuczkowski
Journal:  Curr Opin Obstet Gynecol       Date:  2007-12       Impact factor: 1.927

9.  Treatment of substance abuse during pregnancy and infant outcome.

Authors:  Bertis B Little; Laura M Snell; Toosje T Van Beveren; R Becca Crowell; Stacey Trayler; Walter L Johnston
Journal:  Am J Perinatol       Date:  2003-07       Impact factor: 1.862

10.  Effect of a targeted subsidy on intake of fruits and vegetables among low-income women in the Special Supplemental Nutrition Program for Women, Infants, and Children.

Authors:  Dena R Herman; Gail G Harrison; Abdelmonem A Afifi; Eloise Jenks
Journal:  Am J Public Health       Date:  2007-11-29       Impact factor: 9.308

View more
  6 in total

Review 1.  Perinatal program evaluations: methods, impacts, and future goals.

Authors:  Suzanne D Thomas; Jodi L Hudgins; Donald E Sutherland; Brittany L Ange; Sandra C Mobley
Journal:  Matern Child Health J       Date:  2015-07

2.  Improved birth weight for Black infants: outcomes of a Healthy Start program.

Authors:  Catherine L Kothari; Ruth Zielinski; Arthur James; Remitha M Charoth; Luz del Carmen Sweezy
Journal:  Am J Public Health       Date:  2013-12-19       Impact factor: 9.308

3.  Selected findings from the cross-site evaluation of the Federal Healthy Start Program.

Authors:  Vonna Lou Caleb Drayton; Deborah Klein Walker; Sarah W Ball; Sara M A Donahue; Rebecca V Fink
Journal:  Matern Child Health J       Date:  2015-06

4.  A quasi-experimental design to assess the effectiveness of the federal healthy start in reducing preterm birth among obese mothers.

Authors:  Euna M August; Hamisu M Salihu; Cara Z de la Cruz; Alfred K Mbah; Amina P Alio; Estrellita Lo Berry
Journal:  J Prim Prev       Date:  2015-06

Review 5.  Obesity and mental disorders during pregnancy and postpartum: a systematic review and meta-analysis.

Authors:  Emma Molyneaux; Lucilla Poston; Sarah Ashurst-Williams; Louise M Howard
Journal:  Obstet Gynecol       Date:  2014-04       Impact factor: 7.661

6.  The Impact of Maternal Obesity and Excessive Gestational Weight Gain on Maternal and Infant Outcomes in Maine: Analysis of Pregnancy Risk Assessment Monitoring System Results from 2000 to 2010.

Authors:  Nancy Baugh; David E Harris; AbouEl-Makarim Aboueissa; Cheryl Sarton; Erika Lichter
Journal:  J Pregnancy       Date:  2016-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.